Pioneering research using stem cells to regenerate eye tissue conducted by MCDB’s Dennis Clegg and co-workers may one day help people with age-related macular degeneration (AMD). As the first person to hold the newly endowed Wilcox Family Chair in BioMedicine, Clegg is poised to bring stem-cell-based therapy for AMD to Phase I clinical trials.